Tuesday, 25 Sep 2018

RA/Inflammatory arthritis

Date Typesort ascending Title Save
12 Feb 2016 Social In RA, getting better faster yields best chance of getting to remission. https://t.co/ESnzJy9h4p https://t.co/Uyp0K45yvo
18 Dec 2016 Social Advice on Sex and Rheumatoid arthritis. https://t.co/91RZcOwAoN
29 Mar 2017 Social How do you manage "difficult RA" patients? The ones who "flunked out" of other Rheum clinics and usual therapies?
10 May 2017 Social Stoke uncommon in RA 3.2/1000 PY;3X higher after a serious adverse event Risks higher with age, smoking & ^ lipids https://t.co/XTmYNypg1o
05 Sep 2017 Social 167 #RA pts, serial assessed over 2 yrs; only BMD loss by DXA predicted Xray damage @ 12 & 24 mos;NOT DAS RF CCP ESR https://t.co/u6D6nJdKvx
05 Nov 2017 Social RT @philipcrobinson: Presentation of the arthritis type of checkpoint inhibitor adverse events is often very inflammatory #ACR17 @RheumNow…
02 Jan 2018 Social Autologous stem cell (ASC) Rx looks favorable for systemic sclerosis (https://t.co/JK9oeg8bHC). recent safety review of 18 ASC pts showed 4 death shows a strong need to optimize Pt selection to reduce toxicity. https://t.co/1a7uvHOKur
30 Jan 2018 Social Checkout Dr. Rachel Tate's #ACR17 video on the progress of the ACR RA RISE registry. https://t.co/2cTpDLUIq6
23 Apr 2018 Social FDA Arthritis advisory panel voting on baricitinib safety was 9-6 in favor of 2mg and was 11-4 against the safety of 4 mg
20 Jun 2018 Social Among 113 JIA patients, screening with fecal calprotectin levels found 7/113 with two consecutive elevations of FC. On colonscopy, all patients had IBD. https://t.co/tNoNOuh12Q
10 Sep 2018 Social Red cell distribution width RDW interpretation is a useful tool in clinical practice to distinguish between articular inflammatory and non‐inflammatory joint diseases, as with CRP. RDW seems to be a surrogate marker of the inflammatory process. https://t.co/Z2Ql5FZMxH
14 Jun 2016 Social Smoking and obesity reduce odds of treatment success in early RA - data from 1008 ERA in Canada. #EULAR2016 https://t.co/hpGC3jXDcp
05 Feb 2016 Social NIH shows class II MHC (HLA-DRB1*11 & -HLA-DQA1*05-HLA-DQB1*03) associated w/ ~2 fold increased risk systemic JIA. https://t.co/fkLWoWQfJE
15 Jan 2017 Social RT @ArthritisRes: Calprotectin potential marker for evaluating inflammation and responsiveness in patients with RA on bDMARD treatment http…
06 Apr 2017 Social Dr M Holers shows 1st Degree relatives (FDR) about 16% are RF or CCP positive, increased by smoking @CCF Biologics Summit VII
30 May 2017 Social History, Genetics & Hereditability of #RA reviewed. 1st Dx of RA made 3 Aug 1800; HLA-DR4 discv by Dr P Stastny 1978 https://t.co/8MWOVSlfRN
23 Sep 2017 Social RheumNow Wk in review is up! Watch the video or listen to podcast https://t.co/2FCTVO1btG
07 Nov 2017 Social RT @uptoTate: No power doppler + low MUS gray scale scores in remission pts (DAS-28, CDAI, SDAI, RAPID-3) #ACR17@RheumNow #1879 https://t.c…
25 Jan 2018 Social ADJUVITE Study: 31 JIA pts with chronic uveitis, 4+ yrs of ocular inflammation, studied and there were significantly more responders to adalimumab 9/16 than placebo 3/15. https://t.co/ov87xcqeD9
14 Feb 2018 Social Checkout Dr. Cush Video "Hot Seat" case presentations from RWCS 2018 at RWCS 2018 https://t.co/eYkSKcCUw2